Improving predictability and transparency in DEA and FDA regulation

View on Open Library

Improving predictability and transparency in DEA and FDA regulation

by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health

No reviews yet

First published: 2015 1 language

Subjects

Drugs of abuse Drugs Law and legislation Drug accessibility Drug approval

Reviews

Log in or sign up to write a review.

No reviews yet. Be the first!

More by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health

21st century cures

21st century cures

Medicare reform

Medicare reform

Reauthorization of the Prescription Drug User Fee Act

Reauthorization of the Prescription Drug...

Current issues related to medical liability reform

Current issues related to medical liabil...

Making health care work for American families

Making health care work for American fam...

Keeping the promise

Keeping the promise

You Might Also Like

More in Drugs of abuse

Laws, etc

United States

Aircraft accident report

Aircraft accident report

United States. National Transportation Safety Board.

Drug control

United States. General Accounting Office

VA health care

United States. General Accounting Office

[Gasoline motor-boat for customs service at Corpus Christi, Texas.]

[Gasoline motor-boat for customs service...

United States. Congress. House. Committee on Appropriations

The Perks of Being a Wallflower

The Perks of Being a Wallflower

Stephen Chbosky